Rifadin Capsules

The antibacterial spectrum is similar to that of rifampicin. It has good antibacterial activity against tuberculosis and leprosy. When the dosage is 1/3 of that of rifampicin, similar or higher efficacy can be achieved. It has a good effect on Staphylococcus aureus and has certain antibacterial activity against some Escherichia coli. In addition, it also has an inhibitory effect on Chlamydia trachomatis.

The main ingredient of this product is Rifadin, and its chemical name is: 3-(4-isobutyl-1-piperazinyl) Rifamycin. Molecular formula: C45H63N3O12 Molecular weight: 837.99

This product is suitable for various types of pulmonary tuberculosis and other tuberculosis, including patients who have developed resistance to multiple anti-tuberculosis drugs. It is also used for leprosy and skin diseases caused by sensitive bacteria.

Oral: 150 mg per day for adults under 50 kg and the elderly, 200 mg per day for adults over 50 kg, 3 mg/kg to 5 mg/kg per day for children (maximum dose not exceeding 200 mg). Take once in the morning on an empty stomach.

The adverse reactions are milder than those of rifampicin. It is mildly irritating to the gastrointestinal tract, with occasional nausea, vomiting, diarrhea, etc., but has no obvious damage to the kidneys and hematopoietic system.

It is contraindicated for those who are allergic to this product.

1. This product has synergistic effects with ethambutol, thiosemicarbazide, isoniazid, streptomycin, p-aminosalicylic acid, tetracycline and sulfonamides without cross-resistance. 2. This product has cross-resistance with rifampicin.

Seal tightly and store in a cool, dark place.

0.15g

Fujian Quanzhou Straits Pharmaceutical Co., Ltd.

• Founded in:

  2000-08-02

• Address:

  Room 911, Building 5, Sunshine International Plaza, No. 27, Antai Road, Luojiang District, Quanzhou City, Fujian Province

• Tax NO.:

  91350500717351959W

• Registered Funds:

  $6 million

• Email:

  Log in to view